Optimal dose of sunitinib for long-term treatment in Japanese patients with renal cell carcinoma.
Yamada Y, Ohno Y, Kato Y, Kobayashi R, Hayashi H, Miyahara S, Nakane K, Mizutani K, Yokoi S, Fujii H, Iihara H, Ishihara T, Deguchi T, Sugiyama T, Suzuki A.
Yamada Y, et al. Among authors: sugiyama t.
Cancer Chemother Pharmacol. 2019 Nov;84(5):987-992. doi: 10.1007/s00280-019-03935-x. Epub 2019 Sep 3.
Cancer Chemother Pharmacol. 2019.
PMID: 31482225